LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1
Validating urine-based biomarkers (e.g., exosomal ferroptosis-related proteins and lipid peroxide metabolites) or circulating immune cell ferroptosis signatures that correlate with LN disease activity, pathological grade, or treatment response is urgently needed
Before the general availability of current therapies, hyperthyroidism tended to evolve through periods of exacerbation and remission
Most men tolerate peptide therapy well when dosed appropriately and supervised by a qualified physician, but this requires regular check-ins-not a one-time consultation followed by self-directed use
[DOI] [PubMed] 187.Lee JA, Ku Y, Rhyu IC, Chung CP, Park YJ